Annual report [Section 13 and 15(d), not S-K Item 405]

Financial Instruments and Fair Value Measurements (Tables)

v3.26.1
Financial Instruments and Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured or Disclosed at Fair Value The Company’s assets measured at fair value on a recurring basis were as follows:
December 31, 2025 December 31, 2024
Description Total Quoted prices in active markets for identical assets
(Level 1)
Total Quoted prices in active markets for identical assets
(Level 1)
 amounts in millions
Cash equivalents $ 353  353  52  52